Ulcerative colitis associated with IgG4 cholangitis: Similar features in two HLA identical siblings
IgG4-associated cholangitis (IAC) can mimic primary sclerosing cholangitis although, in contrast to the latter, it is highly responsive to steroid therapy. IAC is known to be associated with autoimmune pancreatitis and has also been shown to be part of a more complex autoimmune IgG4 syndrome. However, an association with inflammatory bowel disease (IBD), a condition in which its identification may have therapeutic and prognostic importance, has not yet been described.
Portal vein thrombosis: A predictable milestone in cirrhosis?
Direct dating of the “Gravettian” Balla child's skeleton from Bükk Mountains (Hungary): unexpected results
News and ViewsInternational audienceDirect dating performed on the Balla's child skeleton evidenced that the remains are more recent as initially presumed and could be attributed to the Neolithic
Neurotrophins and Pain in Endometriosis
Painful Endometrioma Must Make Aware of Deep Endometriotic Lesions
In-situ formation of barium ferrite in iron-doped “tetragonal tungsten bronze”: Elaboration of room temperature multiferroic composites
Recent studies of ceramics of formula Ba2LnFeNb4O15 (Ln=rare earth) with the “tetragonal tungsten bronze” (TTB) structure have correlated their room temperature multiferroics properties to the occurrence of barium ferrite parasitic phases. This work presents the elaboration of Ba2LaFeNb4O15 and Ba2EuFeNb4O15 composite samples with an excess of hematite in the TTB nominal composition. The influence of crystal-chemistry on the phase content and properties of Ba2LnFeNb4O15 TTB composites is discussed. A particular focus on the mechanisms related to the in-situ formation of barium ferrite is given. We show that we can control the spurious ferrite phase in TTB multiferroic composites and thus modulate their magnetic response.
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
This study compared the efficacy of a tetrahydrocannabinol:cannabidiol (THC:CBD) extract, a nonopioid analgesic endocannabinoid system modulator, and a THC extract, with placebo, in relieving pain in patients with advanced cancer. In total, 177 patients with cancer pain, who experienced inadequate analgesia despite chronic opioid dosing, entered a two-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial. Patients were randomized to THC:CBD extract (n = 60), THC extract (n = 58), or placebo (n = 59). The primary analysis of change from baseline in mean pain Numerical Rating Scale (NRS) score was statistically significantly in favor of THC:CBD compared with placebo (improvement of -1.37 vs. -0.69), whereas the THC group showed a nonsignificant change (-1.01 vs. -0.69). Twice as many patients taking THC:CBD showed a reduction of more than 30% from baseline pain NRS score when compared with placebo (23 [43%] vs. 12 [21%]). The associated odds ratio was statistically significant, whereas the number of THC group responders was similar to placebo (12 [23%] vs. 12 [21%]) and did not reach statistical significance. There was no change from baseline in median dose of opioid background medication or mean number of doses of breakthrough medication across treatment groups. No significant group differences were found in the NRS sleep quality or nausea scores or the pain control assessment. However, the results from the European Organisation for Research and Treatment of Cancer Quality of Life Cancer Questionnaire showed a worsening in nausea and vomiting with THC:CBD compared with placebo (P = 0.02), whereas THC had no difference (P = 1.0). Most drug-related adverse events were mild/moderate in severity. This study shows that THC:CBD extract is efficacious for relief of pain in patients with advanced cancer pain not fully relieved by strong opioids.
Fault tolerant control for a dearomatisation process
International audienceIn this paper, a fault tolerant control (FTC) for a dearomatisation process in the presence of faults in online product quality analysers is presented. The FTC consists of a fault detection system (FDI) and a logic for triggering predefined FTC actions. FDI is achieved by combining several process data driven approaches for detecting faults in online quality analysers. The FTC exploits the diagnostic information in adapting a quality controller (MPC) to the faulty situation by manipulating tuning parameters of the MPC to produce both proactive and reactive strategies. The proposed FTC was implemented, tested offline and validated onsite at the Naantali oil refinery. The successful testing and plant validation results are presented and discussed
Total shoulder arthroplasty: Downward inclination of the glenoid component to balance supraspinatus deficiency
Supraspinatus deficiency associated with total shoulder arthroplasty (TSA) provokes eccentric loading and may induce loosening of the glenoid component. A downward inclination of the glenoid component has been proposed to balance supraspinatus deficiency.